Cerus (CERS) Change in Accured Expenses (2010 - 2026)
Cerus' (CERS) quarterly Change in Accured Expenses came in at -$7.5 million in Q1 2026, down 210.35% year-on-year from $6.8 million in Q1 2025, and down 278.88% quarter-over-quarter from $4.2 million in Q4 2025.
Cerus (CERS) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Cerus has disclosed Change in Accured Expenses across 17 years of filings, most recently posting -$7.5 million for Q1 2026.
- Change in Accured Expenses for Q1 2026 came in at -$7.5 million, down 210.35% year-over-year; the trailing twelve-month figure through Mar 2026 was -$828000.0 (up 19.92% YoY), and the FY2025 annual result was $4.3 million, up 294.49% from the prior year.
- Change in Accured Expenses came in at -$7.5 million for Q1 2026 at Cerus, down from $4.2 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $5.9 million in Q4 2022 to a low of -$8.3 million in Q1 2022.
- The 5-year median for Change in Accured Expenses is -$724000.0 (2023), against an average of -$928529.4.
- Across the five-year window, Change in Accured Expenses jumped 828.08% in 2022 and tumbled 498.19% in 2023, its largest moves.
- Cerus' Change in Accured Expenses stood at $5.9 million in 2022, then tumbled by 112.25% to -$724000.0 in 2023, then soared by 471.27% to $2.7 million in 2024, then surged by 56.58% to $4.2 million in 2025, then plunged by 278.88% to -$7.5 million in 2026.
- The last three Change in Accured Expenses figures came in at -$7.5 million (Q1 2026), $4.2 million (Q4 2025), and -$787000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -347.10 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -250.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 145.10 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Cerus | 496.03 Mn | 416.34 Mn | 27.89 Mn | -7.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.53 Mn |
| Mar 31, 2026 | -7.53 Mn |
| Dec 31, 2025 | 4.21 Mn |
| Dec 31, 2025 | 4.21 Mn |
| Sep 30, 2025 | -787,000.00 |
| Sep 30, 2025 | -787,000.00 |
| Jun 30, 2025 | 3.28 Mn |
| Jun 30, 2025 | 3.28 Mn |
| Mar 31, 2025 | -2.43 Mn |
| Mar 31, 2025 | -2.43 Mn |
| Dec 31, 2024 | 2.69 Mn |
| Dec 31, 2024 | 2.69 Mn |
| Sep 30, 2024 | 235,000.00 |
| Sep 30, 2024 | 235,000.00 |
| Jun 30, 2024 | -1.53 Mn |
| Jun 30, 2024 | -1.53 Mn |
| Mar 31, 2024 | -3.59 Mn |
| Mar 31, 2024 | -3.59 Mn |
| Dec 31, 2023 | -724,000.00 |
| Dec 31, 2023 | -724,000.00 |